Zylox-Tonbridge Medical Technology Co., Ltd.

HK$19.39As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2190Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 5Y CAGR (14.82%)
Div yield 1.32%
ROE 9.82%
Medical Devices
Beta (5Y) 0.31
PE TTM 17.59
TSR TTM (17.05%)
Mkt cap HK$6.424B
ROIC 14.56%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$21
10.10%
(30.66%)
Buy 11|8|1|7|2
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.29
0.31
0.33
0.37
42.64%
34.95%
39.35%
38.55%
Revenue¥M
441.0
457.5
468.0
494.3
10.67%
11.51%
12.82%
13.69%
Peers (US$819.5M)
Cap (US$)
PE
885.0M
40.27x
761.9M
22.10x
Capital
TTM
5Y
10Y
Leveragex
0.336
(0.013)
(0.010)
EBIT/Intx
16.14
0.184
0.202
Own earn%
(76.58)
(162.20)
(104.66)
Sh yield%
25.85
51.45
54.05
Owners
Insiders/Inst%
10.35
81.69
Short interest%
4.33
SBC / revenue%
3.61
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
12–18
$1 testx
0.6
Incr. ROIC%
0